Suppr超能文献

β受体阻滞剂治疗患者的运动锻炼强度规划:选择合适方法的重要性。

Programming exercise intensity in patients on beta-blocker treatment: the importance of choosing an appropriate method.

作者信息

Díaz-Buschmann Isabel, Jaureguizar Koldo Villelabeitia, Calero Maria José, Aquino Rosa Sánchez

机构信息

Rey Juan Carlos University Hospital, Madrid, Spain Infanta Elena University Hospital, Madrid, Spain

Infanta Elena University Hospital, Madrid, Spain.

出版信息

Eur J Prev Cardiol. 2014 Dec;21(12):1474-80. doi: 10.1177/2047487313500214. Epub 2013 Aug 5.

Abstract

AIM

To verify the usefulness of current recommended level of target exercise heart rate (HR) and of different HR-based methods for calculating target HR in patients with and without beta-blocker treatment.

METHODS

We studied 53 patients not treated with beta-blocker and 159 patients on beta-blocker treatment. All patients underwent a maximal exercise test with gas analysis, and first ventilatory threshold (VT1 or aerobic threshold), second ventilatory threshold (VT2 or anaerobic threshold), time of exercise, maximum load, metabolic parameters, HR at rest (HRrest), HRpeak, HR at VT1 (HRVT1) and at VT2 (HRVT2), and 75, 80, and 85% of HRmax (HR75%, HR80%, HR85%) were calculated. Exercise HR was also determined using the Karvonen formula, applying 60, 70, and 80% of the heart rate reserve (HRR) (HRKarv0.6, HRKarv0.7, and HRKarv0.8).

RESULTS

This study included 102 patients on a beta-blocker and 39 not treated with negative cronotropic effect drugs. Maximum load, metabolic parameters, HRrest, HRpeak, HRVT1, and HRVT2 were significantly lower in patients on beta-blocker treatment. The proportion of patients with a HR75%, HR80%, HR85%, ​​HRKarv0.6, HRKarv0.7, and HRKarv0.8 VT2 was very high and depended on whether patients were on beta-blocker treatment.

CONCLUSIONS

Prescribed exercise intensity should be within VT1 and VT2, so that the efficacy and safety is guaranteed. If determining VT1 and VT2 is not possible, HR-based methods can be used, but with caution. In fact, there will be always a proportion of patients training below VT1 or above VT2. On the other hand, recommendations for patients on a beta-blocker should be different from patients not receiving a beta-blocker. Patients not treated with a beta-blocker should exercise at HRKarv0.7 or at HR85%. In patients on a beta-blocker, we recommend preferentially a target HR of HRKarv0.6 or HR80%.

摘要

目的

验证当前推荐的目标运动心率(HR)水平以及不同基于心率的目标心率计算方法在接受和未接受β受体阻滞剂治疗的患者中的实用性。

方法

我们研究了53例未接受β受体阻滞剂治疗的患者和159例接受β受体阻滞剂治疗的患者。所有患者均进行了带气体分析的最大运动试验,并计算了第一通气阈值(VT1或有氧阈值)、第二通气阈值(VT2或无氧阈值)、运动时间、最大负荷、代谢参数、静息心率(HRrest)、峰值心率(HRpeak)、VT1时的心率(HRVT1)和VT2时的心率(HRVT2),以及最大心率的75%、80%和85%(HR75%、HR80%、HR85%)。还使用卡尔森公式,应用心率储备(HRR)的60%、70%和80%(HRKarv0.6、HRKarv0.7和HRKarv0.8)来确定运动心率。

结果

本研究纳入了102例接受β受体阻滞剂治疗的患者和39例未接受具有负性变时作用药物治疗的患者。接受β受体阻滞剂治疗的患者的最大负荷、代谢参数、HRrest、HRpeak、HRVT1和HRVT2显著较低。HR75%、HR80%、HR85%、HRKarv0.6、HRKarv0.7和HRKarv0.8 <VT1且>VT2的患者比例非常高,且取决于患者是否接受β受体阻滞剂治疗。

结论

规定的运动强度应在VT1和VT2范围内,以确保疗效和安全性。如果无法确定VT1和VT2,可以使用基于心率的方法,但要谨慎使用。实际上,总会有一部分患者的训练强度低于VT1或高于VT2。另一方面,对于接受β受体阻滞剂治疗的患者的建议应与未接受β受体阻滞剂治疗的患者不同。未接受β受体阻滞剂治疗的患者应在HRKarv0.7或HR85%的心率下运动。对于接受β受体阻滞剂治疗的患者,我们优先推荐目标心率为HRKarv0.6或HR80%。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验